Related Experiment Video
Updated: May 12, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Intravitreal ganciclovir for neonatal cytomegalovirus-associated retinitis: a case report
A Oschman1, V Murthy, R Kollipara
1Department of Pharmacy, Children's Mercy Hospital and Clinics, Kansas City, MO 64108, USA. aoschman@cmh.edu
Insights
Congenital cytomegalovirus (CMV) retinitis can cause vision loss in newborns. This case study shows intravitreal ganciclovir may be a safe and effective treatment option for neonates with this condition.
Area of Science:
- Ophthalmology
- Neonatal Medicine
- Infectious Diseases
Background:
- Congenital cytomegalovirus (CMV) infection is a leading cause of congenital disabilities.
- CMV retinitis (CMVR) affects a significant percentage of infants with congenital CMV.
- Intravitreal ganciclovir is a standard treatment for CMVR in adults but its use in neonates is not documented.
Observation:
- A case report of a term neonate diagnosed with CMVR.
- The neonate received both intravenous and intravitreal ganciclovir.
- Three doses of intravitreal ganciclovir (2 mg per eye) were administered.
Findings:
- Intravitreal ganciclovir treatment was well-tolerated in the neonate.
- Improvement in the infant's retinitis was observed following treatment.
- This suggests intravitreal ganciclovir may be effective for treating CMVR in neonates.
Implications:
- This case suggests a potential new treatment approach for CMVR in neonates.
- Further research is warranted to confirm the efficacy and safety of intravitreal ganciclovir in this population.
- This could lead to improved visual outcomes for infants with congenital CMV infection.
Abstract:
Congenital cytomegalovirus (CMV) infection is a major cause of birth defects and childhood disorders in the United States. Retinitis occurs in 25% of infants with severely symptomatic congenital CMV and in ∼1% of asymptomatic infants. Intravitreal ganciclovir is recommended in adults with CMV retinitis (CMVR) refractory or noncompliant to intravenous therapy. No literature is available discussing the use of intravitreal ganciclovir for CMVR in neonates. We report a term neonate who received intravenous and intravitreal ganciclovir for treatment of CMVR. Three doses of intravitreal ganciclovir (2 mg per dose in each eye) were administered. Intravitreal injections of ganciclovir appeared to be well tolerated and improvement of the retinitis was appreciated. Intravitreal ganciclovir is an effective treatment of CMVR in adult acquired immunodeficiency syndrome (AIDS) patients. We report one case of intravitreal ganciclovir in a term neonate with promising results.
Related Concept Videos
Cytomegalovirus Disease
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Diabetic Retinopathy
